Abstract Body

Background: HIV-associated chronic immune activation and inflammation may contribute to increased risk for kidney disease among HIV-infected (HIV+) individuals, even after viral suppression. We examined associations between inflammatory processes and kidney function in treated and virally suppressed HIV+ and HIV– men from the Multicenter AIDS Cohort Study.

Methods: Glomerular filtration rate (GFR) was directly measured using decay of plasma iohexol concentration. Twelve markers of inflammation were measured from stored blood samples (C-Reactive Protein, Soluble TNF-receptor 2, Soluble Interleukin (IL) 2-receptor-α, Soluble GP130, Soluble CD27, Monocyte Chemoattractant Protein-1, Interferon γ-Induced Protein 10, TNF-α, IL-6, Soluble CD14, IL-8, IL-10). Exploratory factor analysis (EFA) was used to identify underlying inflammatory processes, and factors were validated in an independent dataset. The validated factor scores were used in adjusted logistic regression analyses to evaluate their associations with kidney outcomes: reduced GFR (GFR≤90 ml/min/1.73m2); hyperfiltration (GFR >140 ml/min/1.73m2 – 1 ml/min/1.73m2 for each year over age 40); and urine protein:creatinine ratio (uPCr) category ( ≤100, 100-200, >200 mg/g).

Results: 434 HIV+ men, all on antiretroviral therapy and 80% virally suppressed, and 200 HIV- men had available GFR determinations and inflammatory biomarker levels. HIV+ men had higher levels of cystatin C (median: 0.79 versus 0.75 mg/dl) and uPCr (median: 98 versus 66 mg/g). From the EFA, three factors were retained that accounted for 60% of the total variance in inflammatory marker levels; only the first two factors could be replicated in a validation set. Factor 1 (dominated by markers: sTNF receptor 2, sIL 2-receptor-α, sGP130, sCD27, and sCD14) scores (shown in the Figure) were significantly (p<0.05) related to a greater odds of GFR≤90 ml/min/1.73m2 (OR=2.0), a greater odds of uPCr >200 mg/g (OR=2.2), and a lower odds of hyperfiltration (OR=0.5), as well as with a history of diabetes (OR=1.6) and a history of hypertension (OR=1.3). Levels of all of these markers except GP130 were significantly higher in HIV+ men. Factor 2 (dominated by markers: IL-6, IL-8 and TNF-α) was not significantly associated with any kidney outcomes.

Conclusions: Higher circulating levels of immune activation markers among treated HIV+ individuals, despite virologic suppression, may partially explain their higher burden of kidney dysfunction compared to HIV- persons.

viewer?TAG_ACTION=SECURE_FILE_DOWNLOAD&V
Figure. Distribution of Factor 1 scores across categories of GFR and urine protein:creatinine ratio outcomes.